5-Chloro-2-(pyrrolidin-3-YL)pyrimidine → 1-Hydroxy-4-adamantyl 3-(5-chloropyrimidin-2-yl)pyrrolidine-1-carboxylate
Reaction equation
Cl[C:2]([O:4][CH:5]1[CH:12]2[CH2:13][C:8]3([OH:15])[CH2:9][CH:10]([CH2:14][CH:6]1[CH2:7]3)[CH2:11]2)=[O:3].[Cl:16][C:17]1[CH:18]=[N:19][C:20]([CH:23]2[CH2:27][CH2:26][NH:25][CH2:24]2)=[N:21][CH:22]=1>>[Cl:16][C:17]1[CH:18]=[N:19][C:20]([CH:23]2[CH2:27][CH2:26][N:25]([C:2]([O:4][CH:5]3[CH:12]4[CH2:13][C:8]5([OH:15])[CH2:9][CH:10]([CH2:14][CH:6]3[CH2:7]5)[CH2:11]4)=[O:3])[CH2:24]2)=[N:21][CH:22]=1Participants
3
Procedure
The title compound was prepared following a procedure analogous to that described in Example 19 Step 1 using 1-hydroxy-4-adamantyl chloroformate solution and 5-chloro-2-(pyrrolidin-3-yl)pyrimidine. Two isomers were separated by prep HPLC.
Workup
- customTwo isomers were separated by prep HPLC
Sources & evidence
- ORD record
- ord-3c164ad7eac44f93a60cd183bef885c8
- Source dataset
- uspto-grants-2015_10
- Patent number
- US09163012B2
Reaction notes
Loading…